How we forecast tomorrow’s haemovigilance

IF 1.4 4区医学 Q4 HEMATOLOGY

Transfusion Clinique et Biologique Pub Date : 2024-03-07 DOI:10.1016/j.tracli.2024.03.001

Erica M Wood , Barbee I Whitaker , Mary Townsend , Shruthi Narayan

引用次数: 0

Abstract

The field of haemovigilance continues to develop, building on more than forty years of international experience. This review considers the current scope and activities of haemovigilance around the world and explores aspects of preparation for the advent of new blood products and alternative therapies to transfusion; new tools for data acquisition (including patient- and donor-reported outcomes, and data from ‘wearables’) and the analysis and communication of haemovigilance results.

查看原文本刊更多论文

我们如何预测未来的血液监测？

在四十多年国际经验的基础上，血液警戒领域继续发展。这篇综述探讨了目前全球血液监测的范围和活动，并探讨了为新血液制品和输血替代疗法的出现所做的准备、数据采集的新工具（包括患者和捐献者报告的结果以及来自 "可穿戴设备 "的数据）以及血液监测结果的分析和交流等方面的问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Transfusion Clinique et Biologique 医学-免疫学

CiteScore

2.50

自引率

11.80%

发文量

234

审稿时长

36 days

期刊介绍： Transfusion Clinique et Biologique, the official journal of the French Society of Blood Transfusion (SFTS): - an aid to training, at a European level - the only French journal indexed in the hematology and immunology sections of Current Contents Transfusion Clinique et Biologique spans fundamental research and everyday practice, with articles coming from both sides. Articles, reviews, case reports, letters to the editor and editorials are published in 4 editions a year, in French or in English, covering all scientific and medical aspects of transfusion: immunology, hematology, infectious diseases, genetics, molecular biology, etc. And finally, a convivial cross-disciplinary section on training and information offers practical updates. Readership: "Transfusers" are many and various: anesthetists, biologists, hematologists, and blood-bank, ICU and mobile emergency specialists...